alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Encorium Group, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Niklas Tevajari, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Niklas TevajariNiklas Tevajari(Principal Accounting Officer)




October 3, 2011




The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Page 88930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28394]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Mechanism-Based Adult Stem Cell Treatments for Aging 
Pathologies.
    Date: January 19, 2024.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Birgit Neuhuber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute on Aging, 7201 
Wisconsin Avenue, Gateway Bldg. Suite 3208, Bethesda, MD 20892, 301-
496-3562, <a href="/cdn-cgi/l/email-protection#026c67776a77606770426c6b6c66712c6c6b6a2c656d74"><span class="__cf_email__" data-cfemail="630d06160b16010611230d0a0d07104d0d0a0b4d040c15">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28394 Filed 12-22-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
COMMUNICATIONS

FINANCE & ADMINISTRATION

INSPECTOR GENERAL

GENERAL COUNSEL

HUMAN RESOURCES

EXECUTIVE DIRECTOR

INFORMATION TECHNOLOGY

The Commission

DIVISION OF BUSINESS &

WORKFORCE INVESTMENT

DIVISION OF CRITICAL 

INFRASTRUCTURE

RESEARCH & EVALUATION

FEDERAL CO-CHAIR GOVERNORS/ALTERNATES

APPALACHIAN REGIONAL COMMISSION

ORGANIZATION

Commission Staff
EPA SANITIZED Page 1 of 3
EPA SANITIZED Page 2 of 3
 

EPA SANITIZED Page 3 of 3
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.7    
    


 
 

2005 Amendment to the Providian Financial Corporation Deferred Compensation Plan for Senior Executives and Directors (as amended and restated effective April 1,  1999)
  Effective as of January 1, 2005    

  


        The following amendments to the Providian Financial Corporation Deferred Compensation Plan for Senior Executives and Directors (as amended and restated effective
April 1, 1999; as so amended and restated, the "Plan") are adopted effective January 1, 2005: 



	1.
	Eligibility. A new last sentence is added to Section 3.1 to read as follows: 





"No
Senior Executive or Non-Employee Director shall commence participation in the Plan on or after January 1, 2005." 



	2.
	Deferrals. A new Section 4.6 is added to the Plan to read as follows: 




"4.6
Participants may not make deferrals hereunder on or after January 1, 2005." 



	3.
	Interest. The last sentence of Section 5.4 is deleted, and the two sentences below are added to read as follows: 





"The
interest rate for the quarter shall be equal to the Moody's Corporate Bond Yield Average in effect for the month immediately preceding the beginning of such quarter. In the event that the
Moody's Corporate Bond Yield Average ceases to be available, the Company's chief human resources officer shall substitute a comparable rate of interest to be applied hereunder." 





        Except
as provided in this Amendment, the Plan is hereby ratified and confirmed in all respects. 


        IN
WITNESS WHEREOF this Amendment is adopted this 7th day of February 2005. 



	 	 	PROVIDIAN FINANCIAL CORPORATION
	

 	
 	
By:	

/s/  RICHARD A. LEWEKE      

	 	 	Its:	Vice Chairman and Chief Human Resources Officer













QuickLinks



Exhibit 10.7


2005 Amendment to the Providian Financial Corporation Deferred Compensation Plan for Senior Executives and Directors (as amended and restated effective April 1, 1999) Effective as of January 1, 2005
CONSENT
      OF INDEPENDENT REGISTERED


PUBLIC
      ACCOUNTING FIRM








We
      have
      issued our report dated March 8, 2007, accompanying the consolidated
      financial statements and schedule II (which report expressed an unqualified
      opinion and contains an explanatory paragraph relating to the adoption of
      Statement of Financial Accounting Standards No. 123(R), *Share-Based
      Payment),* included
      in the Annual Report of Aetrium Incorporated on Form 10-K for the year ended
      December 31, 2006. We hereby consent to the incorporation by reference of
      said report in the Registration Statements of Aetrium Incorporated on Forms
      S-8
      (File No. 33-72656, 333-111747, 333-111748).





/s/
      Grant
      Thornton LLP











Minneapolis,
      Minnesota


March
      23,
      2007
```

[Federal Register Volume 75, Number 141 (Friday, July 23, 2010)]
[Notices]
[Page 43225]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18115]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 7091]

Culturally Significant Objects Imported for Exhibition 
Determinations: ``The Holocaust--Uniforms, Canisters, and Shoes''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, and Delegation of Authority No. 
236-3 of August 28, 2000, I hereby determine that the objects to be 
included in the exhibition ``The Holocaust--Uniforms, Canisters, and 
Shoes,'' imported from abroad for temporary exhibition within the 
United States, are of cultural significance. The objects are imported 
pursuant to a loan agreement with the foreign owner or custodian. I 
also determine that the exhibition or display of the exhibit objects as 
part of the permanent exhibit at the U.S. Holocaust Memorial Museum, 
Washington, DC, from on or about September 2010 until on or about 
September 2015, and at possible additional exhibitions or venues yet to 
be determined, is in the national interest. Public Notice of these 
Determinations is ordered to be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Carol B. Epstein, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 202/632-6473). The address is U.S. Department of State, SA-
5, L/PD, Fifth Floor, Washington, DC 20522-0505.

    Dated: July 15, 2010.
Ann Stock,
Assistant Secretary, Bureau of Educational and Cultural Affairs, 
Department of State.
[FR Doc. 2010-18115 Filed 7-22-10; 8:45 am]
BILLING CODE 4710-05-P
```
UNITED STATES DEPARTMENT OF AGRICULTURE 

ANIMAL AND PLANT HEALTH INSPECTION SERVICE 

NATIONAL VETERINARY SERVICES LABORATORIES 

SUBMISSION FORM 

IVERMECTIN CORN TREATMENT 

***THIS FORM MUST BE USED WITH VS FORM 10-4 (SPECIMEN SUBMISSION). DO NOT SUBMIT ALONE.*** 

See reverse for instructions. 

1. SUBMITTER NAME (AS LISTED ON ACCOMPANYING VS FORM 10-4) 

2. IVERMECTIN LOT NUMBER 3. DATE TREATED 

4. LOCATION OF TREATMENT 5. APHIS EMPLOYEE APPLYING TREATMENT 

6. TOTAL WEIGHT (LB) CORN TREATED 7. TOTAL VOLUME (L) IVERMECTIN ADDED 

8. DATE SAMPLES SHIPPED 

VS 4-8 

MAR 2010 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INSTRUCTIONS FOR COMPLETING VS FORM 4-8 

This form is used by APHIS-VS employees verifying the final concentration of ivermectin in corn treated as part of the USDA’s Tick Surveillance Program. This form is intended to 

accompany VS Form 10-4. 

1. SUBMITTER NAME 

Enter the submitter’s name, exactly as is appears on VS Form 10-4. 

2. IVERMECTIN LOT NUMBER 

Enter the lot number of the ivermectin concentrate that was used to treat the corn. 

3. DATE TREATED 

Enter the date (MMDDYYYY format) the corn was treated with ivermectin. 

4. LOCATION OF TREATMENT 

Enter the city and/or county where the corn was treated. 

5. APHIS EMPLOYEE APPLYING TREATMENT 

Enter the name of the APHIS employee preparing the treated corn. 

6. TOTAL WEIGHT (LB) CORN TREATED 

7. TOTAL VOLUME (L) IVERMECTIN ADDED 

8. DATE SAMPLES SHIPPED 

Enter the date the treated corn samples were shipped to the NVSL (MMDDYYYY format) 

INSTRUCTIONS FOR COLLECTING AND SUBMITTING SAMPLES 

Take one sample near the beginning of treatment and another near the end of treatment for the corn lot, not exceeding 2 samples per treatment. Identify the sample collected near 

the beginning as Sample A and the sample near the end as Sample B. 

SPECIAL INSTRUCTIONS FOR COMPLETING VS FORM 10-4, BLOCK 21 (SAMPLE ID) WHEN ACCOMPANIED BY VS FORM 4-8:

Configure the Sample ID in a format including the date the corn was treated, followed by a location identifier and “A” or “B” as described above. 

Example: Sample from February 10, 2010, taken in Laredo from the beginning of the treatment run = 

Sample ID 2-10-10-L-A 

INSTRUCTIONS FOR SUBMITTING SAMPLES: 

Place the two labeled samples in a large zipper-closure bag, seal it, and place in a shipping box. Add completed VS Forms 10-4 and 4-8 to the box and ship to: 

Chemistry and Analytical Services Section 

National Veterinary Services Laboratories 

USDA-APHIS-VS 

1920 Dayton Ave 

Ames, IA 50010 

Phone: 515-337-7514
Copa Airlines

0816

- 06819

Panamá, Rep. Panamá 

### Tarifas

March 31 , 201 3

U.S. Department of Transportati on 1200 New Jersey Avenue, S.E. Washington, D.C. 20590

To Whom It May Concern,

In the past fifteen years, airlines have revolutionized their direct channels by merchandizing their products more effectively through the internet; but the major distribution channel, travel agencies, remains steady. Travel agencies utilize a technology p latform based on EDIFACT technology, which was designed when propeller planes dominated the skies. This technological infrastructure presents many constraints for airlines to push merchandising through their travel agents, deal with customers equally along all channels, and mitigate the presence of unproductive practices from travel agents.

Airlines need to be able to merchandise their products and services in an efficient way through their biggest distribution channel, traditional agencies. In the current GDSs system, travel agents can only provide passengers with base fare and availability from the airline. Special offers and/or promotions based on passenger’s profile (frequent flyer status, etc) cannot even be considered. New Distribution Capability (NDC) allows a common messaging standard based on XML (the same standard used on the

interne t) that is robust enough to support both complete offers and the ability of airlines to customize
their offers to meet individual traveler needs.

These individual traveler’s needs are being addressed effectively by airlines through their own websites, in which they are able to display information about fare alternatives, ancillary services, on

board amenities and graphics such as pictures or seat maps. However, in the dominant distribution channel, passengers can only base their decisions on the two factor s that have driven the industry to commoditization: price and availability, and as a result, this has created an environment of asymmetrical information between the indirect and direct channels for passengers.

Finally, the XML messaging standards would all ow airlines to have more effective controls over unproductive practices of the agents such as churning or non

- cancelled segments, which in turn will lead to better availability and fares for the end user.Once the NDC is adopted, it will result in airline s competing directly with one another not only on

fares, but on product and service offerings, and on an infrastructure that is current and robust enough to satisfy the needs of a more dynamic, savvy and demanding traveler.

Best Regards,

Y on I. Jayo Third Party Distribution Manager Copa Airlines  yjayo@copaair.com

 (507) 304

- 2782  (507) 6450

- 7633
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

TERRANCE J. ZICH, ) ) Appellant, ) ) v. ) Case No. 2D17-5076 ) MARIO BAUTISTA-DIAZ and ANIBEXY ) MIRANDA; and CITIZENS PROPERTY ) INSURANCE CORPORATION, ) ) Appellees. ) 

### ) Opinion filed March 13, 2019. Appeal from the Circuit Court for Hillsborough County; Paul L. Huey, Judge. David L. Ross of the Law Offices of David L. Ross, P.A., Miami, for Appellant. Jonathan D. Franklin of Franklin Legal Group, P.A., Miami, for Appellee Citizens Property Insurance Corporation. No appearance for Appellees Mario Bautista-Diaz and Anibexy Miranda.

PER CURIAM.

This proceeding is converted to a petition for writ of certiorari. See Winderting Invs., LLC v. Furnell, 144 So. 3d 598, 602 (Fla. 2d DCA 2014) ("An order- 2 -

compelling the production of documents by a nonparty is reviewable by certiorari because he or she has no adequate remedy by appeal.").

Denied.
KELLY, KHOUZAM, and SLEET, JJ., Concur.
**EXHIBIT 8**

 

Subsidiaries of the Registrant

 

**Brazauro Resources Corporation**

(a British Columbia corporation)

 

Owns 100% of the following corporations:

 

Star U.S. Inc.

(a Delaware corporation)

 

and

 

Brazauro Holdings (Brazauro) Ltd.

(a British Columbia corporation)

 

Brazauro Resources Corporation owns 98% of:

 

Jaguar Resources do Brasil Ltda.

(a Brazilian corporation)

 

 

Brazauro Holdings (Brazauro) Ltd. owns 2% of:

 

Jaguar Resources do Brasil Ltda.

(a Brazilian corporation)

 

 

Star U.S. Inc. Owns 100% of the 

following three corporations:

 

Diamond Operations, Inc. (a Delaware corporation)

Diamond Exploration, Inc. (an Arkansas corporation)

Continental Diamonds, Inc. (an Arkansas corporation)

 

 

 

 

----
##### 



Exhibit 31.3 CERTIFICATION BY TREASURER
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Paul H. Askegaard, Treasurer of Aetrium Incorporated, certify that: 1. I have reviewed this annual report on Form 10-K of Aetrium Incorporated; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this
report; 3. Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrants other certifying officers and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; (b) Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures as of the end of the period covered by this report based on such evaluation; and (c) Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of this annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and 5. The registrants other certifying officers and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit
committee of registrants board of directors (or persons performing the equivalent function): (a) All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the registrants internal control over financial reporting. Date: March 30, 2005
    
    
    
    /s/ Paul H. AskegaardBy:
    
    Paul H. AskegaardTitle:
    
    Treasurer (principal financial and
accounting officer)
[Federal Register Volume 88, Number 242 (Tuesday, December 19, 2023)]
[Presidential Documents]
[Page 87891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28106]



[[Page 87889]]

Vol. 88

Tuesday,

No. 242

December 19, 2023

Part III





The President





-----------------------------------------------------------------------



Notice of December 18, 2023--Continuation of the National Emergency 
With Respect to Serious Human Rights Abuse and Corruption


                        Presidential Documents 



Federal Register / Vol. 88 , No. 242 / Tuesday, December 19, 2023 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 87891]]

                Notice of December 18, 2023

                
Continuation of the National Emergency With 
                Respect to Serious Human Rights Abuse and Corruption

                On December 20, 2017, by Executive Order 13818, the 
                President declared a national emergency with respect to 
                serious human rights abuse and corruption around the 
                world and, pursuant to the International Emergency 
                Economic Powers Act (50 U.S.C. 1701 et seq.), took 
                related steps to deal with the unusual and 
                extraordinary threat to the national security, foreign 
                policy, and economy of the United States.

                The prevalence and severity of human rights abuse and 
                corruption that have their source, in whole or in 
                substantial part, outside the United States, continue 
                to pose an unusual and extraordinary threat to the 
                national security, foreign policy, and economy of the 
                United States. For this reason, the national emergency 
                declared on December 20, 2017, must continue in effect 
                beyond December 20, 2023. Therefore, in accordance with 
                section 202(d) of the National Emergencies Act (50 
                U.S.C. 1622(d)), I am continuing for 1 year the 
                national emergency declared in Executive Order 13818 
                with respect to serious human rights abuse and 
                corruption.

                This notice shall be published in the Federal Register 
                and transmitted to the Congress.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    December 18, 2023.

[FR Doc. 2023-28106
Filed 12-18-23; 11:15 am]
Billing code 3395-F4-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF PERFORMANCE FOOD GROUP COMPANY FOR THE YEAR ENDED 
DECEMBER 27, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-27-1997
<PERIOD-START>                             DEC-29-1996
<PERIOD-END>                               DEC-27-1997
<CASH>                                           3,653
<SECURITIES>                                         0
<RECEIVABLES>                                   82,734
<ALLOWANCES>                                     2,680
<INVENTORY>                                     72,951
<CURRENT-ASSETS>                               159,594
<PP&E>                                         108,367
<DEPRECIATION>                                  36,557
<TOTAL-ASSETS>                                 288,883
<CURRENT-LIABILITIES>                          106,810
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           125
<OTHER-SE>                                     133,848
<TOTAL-LIABILITY-AND-EQUITY>                   288,883
<SALES>                                      1,230,078
<TOTAL-REVENUES>                             1,230,078
<CGS>                                        1,074,154
<TOTAL-COSTS>                                1,206,648
<OTHER-EXPENSES>                                   105
<LOSS-PROVISION>                                   331
<INTEREST-EXPENSE>                               1,991
<INCOME-PRETAX>                                 21,544
<INCOME-TAX>                                     8,297
<INCOME-CONTINUING>                             13,247
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,247
<EPS-PRIMARY>                                     1.11
<EPS-DILUTED>                                     1.06
        

</TABLE>